Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
192.30
+14.65 (8.25%)
Nov 6, 2026, 4:00 PM EST - Market closed
Revolution Medicines Employees
Revolution Medicines had 883 employees as of December 31, 2025. The number of employees increased by 349 or 65.36% compared to the previous year. That makes Revolution Medicines the 15,785th largest employer in the world and 2,277th in the United States.
Employees
883
Change (1Y)
349
Growth (1Y)
65.36%
Revenue / Employee
$223,736
Profits / Employee
-$2,118,387
Market Cap
41.59B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 883 | 349 | 65.36% |
| Dec 31, 2024 | 534 | 156 | 41.27% |
| Dec 31, 2023 | 378 | 132 | 53.66% |
| Dec 31, 2022 | 246 | 58 | 30.85% |
| Dec 31, 2021 | 188 | 63 | 50.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,343 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Genmab | 3,119 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
RVMD News
- 9 hours ago - Revolution Medicines price target raised to $350 from $280 at H.C. Wainwright - TheFly
- 1 day ago - Revolution Medicines price target raised to $272 from $255 at Morgan Stanley - TheFly
- 1 day ago - This pancreatic cancer treatment is on track for ‘one of the best drug launches of all time' - Market Watch
- 1 day ago - Revolution Medicines price target raised to $321 from $260 at RBC Capital - TheFly
- 1 day ago - Revolution Medicines price target raised to $270 from $250 at TD Cowen - TheFly
- 1 day ago - Revolution Medicines price target raised to $298 from $275 at Guggenheim - TheFly
- 1 day ago - Revolution Medicines price target raised to $340 from $320 at Evercore ISI - TheFly
- 1 day ago - Revolution Medicines price target raised to $274 from $264 at BofA - TheFly